Home
Mission Statement:
Founded in 2009, Favus Institutional Research LLC is an independent healthcare equity research firm for institutional investors. We provide institutional investors with money-making healthcare research and divergent information. We use fundamental analysis to evaluate the healthcare sector, with a focus on commercial, clinical data, legal, reimbursement, and regulatory catalysts. The firm is run by Elliot Favus, M.D., who has equity research and institutional investment management experience at Lazard Capital Markets and Och-Ziff Capital Management Group.
To learn about our active research reports, please email Elliot@FavusLLC.com
Active Research Ideas:
ABMD
ARIA
ARQL
AVNR
CELGZ
IDIX
MAKO
QCOR
SGEN
SPPI
SQNM
Past Reports (Inactive):
FRX (Sell Recommendation)
EW (Sell Recommendation)
VRUS (Sell Recommendation)
VRTX (Sell Recommendation)
MDVN (White Paper)
WCRX (Sell Recommendation)
DNDN (Sell Recommendation)
SVNT (Sell Recommendation)
EW (Sell Recommendation)
TH (Sell Recommendation)
ALKS (Sell Recommendation)
SQNM (Sell Recommendation)
DCTH (Sell Recommendation)
ACOR (Sell Recommendation)
NUVA (Sell Recommendation)
AGAM (Sell Recommendation)
VVUS (Sell Recommendation)
CADX (Sell Recommendation)
THOR (Sell Recommendation)
VRTX (Sell Recommendation)
RDEA (Sell Recommendation)
ALTH (Buy Recommendation)
PLX (Sell Recommendation)
VITA (Sell Recommendation)
HGSI (Buy Recommendation)
KNSY (Sell Recommendation)
BioMS (Sell Recommendation)
STSI, now CIGX (Sell Recommendation)
SQNM (Sell Recommendation)
EBS (Sell Recommendation)